Eton Pharmaceuticals (ETON) Stock Statistics & Valuation Metrics

Eton Pharmaceuticals has a market cap or net worth of $333.88M. The enterprise value is $143.37M.

Eton Pharmaceuticals has 26.82M shares outstanding. The number of shares has decreased by -2.65% in one year.

Eton Pharmaceuticals’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -4.64%.

The current PE Ratio of Eton Pharmaceuticals is -90.22. Eton Pharmaceuticals’s PEG ratio is -0.29.

In the last 12 months, Eton Pharmaceuticals had revenue of $39.01M and earned -$3.82M in profits. Earnings per share was -$0.15.

In the last 12 months, operating cash flow was $969.00K and capital expenditures -$8.15M, giving a free cash flow of -$7.18M billion.

Eton Pharmaceuticals pays an annual dividend of , resulting in a dividend yield of

Eton Pharmaceuticals upcoming earnings date is May 8, 2025, TBA.

Eton Pharmaceuticals as a current ratio of 2.06, with Debt / Equity ratio of <0.01

In the past 12 months, Eton Pharmaceuticals has paid $223.72K in taxes.

Eton Pharmaceuticals EV to EBITDA ratio is -127.11, with an EV/FCF ratio of 350.04.

Eton Pharmaceuticals has $14.94M in cash and marketable securities with $29.92M in debt, giving a net cash position of $14.98M billion.

Gross margin is 60.01%, with operating margin of -6.66%, and net profit margin of -9.80%.

The average price target for Eton Pharmaceuticals is $28.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy